Company / Operating Margin
Harmony Biosciences Holdings, Inc. Operating Margin History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
24.0%
FY2025
5-year range
-2433.8% / 33.0%
FY2021-FY2025
Trend
-10.1%
vs FY2024
Sector context
#22 of 135
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s operating margin of 24.0% is higher than 84% of companies in the Health Care sector (FY2025). Declined from 33.0% to 24.0% over the past 2 years.
Based on SEC 10-K filings.
24.0% in FY2025 with a 5-year CAGR of +2457.8%. Top quartile in the Health Care sector.
Declined from 33.0% to 24.0% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -3.5pp
- 5-Year Change
- +2457.8pp
- 10-Year Change
- -
Sector benchmark
Top 16% in Health CareTop 16% of 135This company 24.0% Sector average -774.4%
▼
+103.1% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 10.1% year-over-year.
- Currently 798.4pp above the Health Care sector average.
- Peak operating margin was recorded in FY2023.
- Lowest operating margin in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 24.0% | -10.1% |
| FY2024 | 26.7% | -19.1% |
| FY2023 | 33.0% | +20.2% |
| FY2022 | 27.5% | +101.1% |
| FY2021 | -2433.8% | +0.0% |
| FY2020 | -2433.8% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026